Clinical trial: A Phase 1b Multicenter, Non-randomized, Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of Single Ascending Doses of a New Subcutaneous Formulation of Ocrelizumab in Patients With Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07667322?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24361

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A PHASE III, OPEN-LABEL, SINGLE-ARM, MULTI-CENTER STUDY TO EVALUATE THE SAFETY AND USE OF AN ON-BODY DELIVERY SYSTEM FOR THE SUBCUTANEOUS HOME ADMINISTRATION OF OCRELIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-523726-40-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24348

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Effect of Specialised Physiotherapy and Supportive Psychotherapy on Clinical Status, Neuroplasticity, and Quality of Life in People With Multiple Sclerosis: A Prospective Interventional Study With a Self-Controlled Design

https://clinicaltrials.gov/study/NCT07666958?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24347

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

https://gregory-ms.com/articles/319098/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_319098

#MultipleSclerosis #MSchat #MS #Neurology

https://gregory-ms.com/articles/319122/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_319122

#MultipleSclerosis #MSchat #MS #Neurology

Clinical trial: An Open-Label Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2025-524164-37-00?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24338

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Development of Pain Management Just-In-Time Adaptive Interventions (JITAI) Content in Multiple Sclerosis and Spinal Cord Injury

https://clinicaltrials.gov/study/NCT07663266?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24337

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: A First-in-Human, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intrathecally Administered LTX-002 in Adult Participants With Amyotrophic Lateral Sclerosis

https://clinicaltrials.gov/study/NCT07660614?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24327

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

Clinical trial: Integrative Training Approach for Inducing Neuroplasticity in Multiple Sclerosis

https://clinicaltrials.gov/study/NCT07660601?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_24328

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology

https://gregory-ms.com/articles/318930/?utm_source=fediverse&utm_medium=mastodon&utm_content=article_318930

#MultipleSclerosis #MSchat #MS #Neurology